2m 2m 2m 2m 2m 2m 2m
TELOMIR PHARMA (TELO)
NASDAQ
$0.62+$0.03 (+4.20%)
Price as of Nov 12, 2026 7:51 AM EST- $43.8MMarket Cap
- -55.93%1-Year Change
- BiotechnologyIndustry
TELOMIR PHARMA (TELO)
$0.62+$0.03 (+4.20%)
TELO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.59 | ||
Change | +$0.02 (+4.00%) | ||
Open | $0.59 | ||
High | $0.71 | ||
Low | $0.57 | ||
Previous Close | $0.57 | ||
Volume | 322,545 | ||
30-Day Average Volume | 111,637 | ||
1-Week Change | -32.00% | ||
1-Month Change | -46.87% | ||
1-Year Change | -55.93% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.7M | ||
Total Assets | $4.6M | ||
Market Cap | $43.8M | ||
Enterprise Value | $39.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$705,225.00 | ||
Free Cash Flow | -$586,439.00 | ||
EBIT | -$705,225.00 | ||
EBITDA | -$705,225.00 | ||
Net Working Capital | $4.4M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -56 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -60 | ||
PEG | -1 | ||
Price/Free Cash Flow | -75 | ||
Price/Operating Cash Flow | -75 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue